Double-blind, parallel-group confirmatory study of AD-810N (zonisamide) in patients with Parkinson's disease
Latest Information Update: 07 Jan 2022
At a glance
- Drugs Zonisamide (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
Most Recent Events
- 21 May 2016 New trial record